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Abstract
Background:  A mannosyltransferase gene (ALG9,  DIBD1) at chromosome band 11q23 was
previously identified to be disrupted by a balanced chromosomal translocation t(9;11)(p24;q23) co-
segregating with bipolar affective disorder in a small family. Inborn ALG9 deficiency (congenital
disorders of glycosylation type IL) is associated with progressive microcephaly, seizures,
developmental delay, and hepatomegaly. It is unknown whether common variations of ALG9
predispose to bipolar affective disorder.
Methods: We tested five polymorphic markers spanning ALG9 (three intragenic and one upstream
microsatellite repeats and one common missense variation, V289I (rs10502151) for their
association with bipolar I disorder in two pedigree series. The NIMH (National Institute of Mental
Health) pedigrees had a total of 166 families showing transmissions to 250 affected offspring,
whereas The PITT (The University of Pittsburgh) pedigrees had a total of 129 families showing
transmissions to 135 cases. We used transmission disequilibrium test for the association analyses.
Results: We identified three common and distinct haplotypes spanning the ALG9 gene. We found
no statistically-significant evidence of transmission disequilibrium of marker alleles or multi-marker
haplotypes to the affected offspring with bipolar I disorder.
Conclusion: These results suggest that common variations in ALG9 do not play a major role in
predisposition to bipolar affective disorder.
Background
Family, twin and adoption studies indicate a strong
genetic contribution to the etiology of bipolar affective
disorder (BPAD) [1]. The genetics of bipolar disorder,
however, is complex and probably involves multiple
genes interacting with each other and environmental
components. Currently, susceptibility genes for BPAD and
their mechanism of action in disease predisposition are
largely unknown. Identification of certain susceptibility
genes for BPAD could be facilitated by studying rare fam-
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ilies where the disease co-segregates with a chromosomal
abnormality among multiple affected relatives [2]. Previ-
ously, we described a family with five individuals affected
with Bipolar I disorder in three generations and one indi-
vidual with recurrent unipolar depression [3]. All six
affected individuals were carriers of a balanced chromo-
somal translocation t(9;11)(p24;q23). Although five
other individuals carrying the translocation were clinically
normal at the time of the diagnostic interview, the
absence of any affected individuals without the transloca-
tion suggested reduced penetrance of the chromosomal
aberration in the causation of BPAD in this family. Subse-
quently, we captured and characterized the breakpoint
junctions of both derivative chromosomes 9 and 11 using
somatic cell hybridization methods [4]. We found that a
mannosyltransferase gene, ALG9 (Asparagine-Linked Gly-
cosylation mutant 9;DIBD1, Disrupted In Bipolar Disor-
der 1), at chromosome 11q23 was physically disrupted by
the translocation breakpoint [5]. The translocation dis-
rupted ALG9, which is composed of 15 exons spread to
approximately 82 kb genomic distance, between exons 9
and 10 (Figure 1). No gene was disrupted at the chromo-
some band 9p24 breakpoint.
ALG9  encodes a mannosyltransferase protein which is
involved in the synthesis of lipid-linked oligosaccharides
(LLOs) in the protein N-glycosylation pathway [6]. ALG9
is ubiquitously expressed in different anatomical regions
of the central nervous system. N-linked glycosylation is
essential for the modification of proteins in eukaryotes
A schematic view of the ALG9 gene structure and the relative locations of the five polymorphic markers Figure 1
A schematic view of the ALG9 gene structure and the relative locations of the five polymorphic markers. Verti-
cal lines represent the exons and lightening bolt represents the location of the translocation breakpoint. Relative positions of 
the exons and the markers are approximately in scale. The bottom part contains a table that describes common alleles of the 
markers, which were used in the transmission disequilibrium test, and their frequencies in the PITT sample.
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and is one of the most complex metabolic pathways
known, involving more than 40 biochemical steps. Con-
genital disorders of glycosylation type I (CDG-I), an
increasingly recognized and expanding group of genetic
conditions, are caused by abnormalities in the synthesis
of the LLOs or in their attachment to proteins [7]. Most
affected children have multi-system involvement indicat-
ing the importance of normal protein glycosylation in cel-
lular function. CDG are clinically associated with a broad
range of symptoms including the failure to thrive, hypot-
onia, cerebellar dysfunction, seizures, mental retardation,
and coagulopathy.
The deletion of the ALG9 gene in yeast results in accumu-
lation of LLOs and in hypoglycosylation of secreted pro-
teins, suggesting that the ALG9 protein product functions
in the addition of terminal α-1, 2- or α-1, 6-mannoses in
the endoplasmic reticulum during the stepwise assembly
of LLO [8]. Recently, the first human cases of ALG9 defi-
ciency (congenital disorders of glycosylation type IL;
CDG-IL), caused by E523K [9] and Y286C [10]
homozygous missense mutations, were described in two
infants. The mutations caused an accumulation of lipid-
linked-GlcNAc(2)Man(6) and -GlcNAc(2)Man(8) struc-
tures and led to transfer of incomplete oligosaccharides
precursors to protein. Both infants exhibited progressive
microcephaly, seizures, developmental delay, and
hepatomegaly. Also, there were additional clinical fea-
tures common to other forms of CDG, including cystic
renal disease, pericardial effusion and tamponade, partial
villous atrophy, hypoproteinemia, esotropia, inverted
nipples, coagulopathy, and brain imaging findings that
suggested cerebral and cerebellar atrophy. Systemic fea-
tures of the affected cases were consistent with the ubiqui-
tous gene expression pattern and the central nervous
system defects suggested a critical role for ALG9 in neuro-
genesis or in neuronal survival. To test whether common
variations in the ALG9 gene are associated with BPAD, we
performed a family-based association analysis using two
pedigree series.
Methods
We previously evaluated linkage and linkage disequilib-
rium in the NIMH (National Institute of Mental Health)
bipolar pedigrees [5]. The NIMH pedigrees include series
1 which consisted of 22 multiplex families that were pre-
viously used in chromosomal and genomic scans and
series 2, which is a collection of 97 pedigrees from the
NIMH Genetics Initiative for bipolar disorder [11]. In our
earlier analyses, two hierarchical phenotype models,
Affection Status Model (ASM) I and ASM II were used.
ASM I included bipolar I, bipolar II with major depres-
sion, and schizoaffective illness, and ASM II included phe-
notypes in ASM I plus recurrent unipolar disorder. These
analyses did not show evidence of statistically significant
linkage or linkage disequilibrium to the ALG9 gene using
ASM I and ASM II as diagnostic categories. Here, we
extend our analyses of the ALG9 gene with a family-based
study of genetic association in a new pedigree series that
is composed of 133 small nuclear families that have been
collected at the University of Pittsburgh (PITT). We con-
fine our analyses to cases with a diagnosis of bipolar I dis-
order, because this was the diagnosis assigned to the five
translocation carriers in the original translocation pedi-
gree. The PITT series contain exclusively bipolar I cases.
We also include the NIMH series after recoding of the
diagnoses: bipolar I cases are recoded as "affected" and all
other psychiatric diagnoses as "unknown" (Table 1). The
collection and genetic study of the PITT families were
approved by the University of Pittsburgh IRB committee.
Genotyping was performed using four simple tandem
repeat polymorphisms (STRPs) and one missense single
nucleotide polymorphisms [5]. Our earlier sequence anal-
ysis of 60 subjects with BPAD provided us with a poly-
morphism profile of the gene. A non-synonymous single
nucleotide polymorphism (SNP), V289I (rs10502151),
had the highest minor allele frequency (0.35) among the
four SNPs discovered. The SNP, V289I (rs10502151), in
exon 8 of ALG9 was genotyped by PCR amplification and
restriction enzyme digestion as described earlier [5]. The
STRPs pDJ159O1-GT2 (D11S5025; GenBank:
AF113397), -GT1 (D11S5026; GenBank: AF113398), -
TAT (D11S5027; GenBank: AF113399), and -CA
(D11S5028; GenBank: AF113400) were originally devel-
oped during fine mapping of the hereditary paragangli-
oma type 1 critical region at chromosome band 11q23
[12] and later mapped in and around the ALG9 gene. The
information on the allelic distributions of the STRPs is
available in Genome Database. These four markers are
Table 1: Characteristics of the bipolar pedigree series analyzed for association with ALG9
Pedigree Series Structure of pedigrees Total No. of 
nuclear families
Total No. of subjects 
in the series
No. of families with 
transmissions to 
affected offspring
Total No. of bipolar I 
cases
PITT trios, duos, sib pairs with two, one 
or no parents
133 424 129 135
NIMH Multi-generational with multiple 
affected subjects
306 1903 166 250Behavioral and Brain Functions 2006, 2:25 http://www.behavioralandbrainfunctions.com/content/2/1/25
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tightly linked and are distributed within an approximate
82-kb region (Figure 1). D11S5028 is located ~19 kb
upstream of the transcription start site, whereas the other
three STRPs are located within gene introns.
We used TRANSMIT software to test for association in
complete and incomplete families [13]. TRANSMIT is a
generalization of the Transmission Disequilibrium Test
(TDT) and uses the Expectation Maximization (EM) algo-
rithm to estimate the missing information. The test statis-
tic of TRANSMIT reduces to that of the TDT when families
are full trios and markers are diallelic. When one parent
and one affected sib (duos) or one affected and one
healthy sib are available per family TRANSMIT can be
used to perform the TDT analysis [14].
Results and discussion
Transmission disequilibrium test of markers
We evaluated the PITT and the NIMH series of pedigrees
for association with the five polymorphic markers in the
ALG9  gene. The TRANSMIT program provided the
observed and the expected number of transmissions for
each of the common alleles of the five markers from a par-
ent to an affected offspring. The transmission patterns of
the marker alleles to affected offspring did not show sta-
tistical significance. Specifically, in the PITT series, the
SNP alleles encoding for Val289 and Ile289 were trans-
mitted 185 and 85 times, similar to the expected transmis-
sion numbers of 187.5 and 82.5, respectively. Similarly,
transmissions of the SNP alleles occurred 343 and 157
times in the NIMH series, which is very close to the
expected numbers of 344 and 156, respectively. TRANS-
MIT provided χ2-based significance tests for transmission
disequilibrium for each marker allele and for global
(including all marker alleles) transmission disequilib-
rium. For robustness, the p-values associated with the glo-
bal tests were computed via 1000 bootstrap samples.
Bootstrap p-values were very close to the ones computed
using the asymptotic χ2 distribution of global tests. None
of the common alleles of the five markers yielded statisti-
cally significant evidence for transmission disequilibrium.
The results of the global χ2 tests are presented in Table 2.
Transmission disequilibrium test of haplotypes
We wished to evaluate ALG9 further as a susceptibility
gene for bipolar I using haplotype transmission disequi-
librium tests. We tested D11S5028-V289I (rs10502151)-
D11S5027 haplotypes in the PITT series and D11S5028-
V289I (rs10502151) haplotypes in the NIMH series.
These markers were selected for analyses because we were
particularly interested in testing the haplotypic variations
distinguishing the alleles encoding V289I (rs10502151), a
common non-synonymous conservative substitution pol-
ymorphism. V289I (rs10502151) is biologically interest-
ing because the amino acid Valine is conserved in the
ALG9 gene in other species including fruit fly (Drosophila
melanogaster), nematode (Caenorhabditis elegans), plant
(Arabidopsis thaliana), fission yeast (Schizosaccharomyces
pombe) and baker's yeast (Saccharomyces cerevisiae) [5]. We
found non-random allelic associations among the mark-
ers (Table 3). The non-ancestral ALG9  allele encoding
Ile289 was associated with the 110-bp and 372-bp alleles
of D11S5028 and D11S5027, respectively (haplotypes 2.2
and 2.2.2 in Table 3). None of the haplotypes showed sta-
tistically significant evidence of transmission disequilib-
rium to offspring affected by bipolar I (Table 3). These
results indicate that common allelic variations of the five
markers than span ALG9  and haplotypic variations of
V289I (rs10502151)-D11S5027 and D11S5028-V289I
(rs10502151) are not associated with Bipolar I neither in
the NIMH or the PITT pedigree series, which collectively
contain 295 families showing transmissions to 385
affected offspring. These results are in agreement with our
earlier results in the NIMH pedigree series obtained using
broader diagnostic criteria and a different analytical
approach [5].
To test whether the variations revealed by our multi-
marker haplotypes represented the true haplotypic diver-
sity in the ALG9 gene, we assessed its haplotype block
structure in Caucasians in the HapMap database [15],
because virtually all of our samples were of Caucasian ori-
gin. The common haplotypes of ALG9 in the HapMap
database were defined by 18 intronic SNPs and the V289I
(rs10502151) in 60 Caucasian samples (see Additional
File 1). The non-ancestral allele encoding Ile289 (allele T
of rs10502151) is associated with a common haplotype
(HMB1) that has a frequency of 23%, whereas the remain-
ing four haplotypes, HMA1, HMA1a, HMA2 and HMA2a,
are associated with the ancestral allele encoding Val289
(allele C of rs10502151). Notably, only a single intronic
SNP distinguishes HMA1 from HMA1a (SNP#19), and
HMA2 from HMA2a (SNP#16), suggesting a recent com-
mon origin for these haplotype-duos. Thus, HMA1/
Table 2: Global TRANSMIT statistics for transmission disequilibrium tests of association between ALG9 variations and bipolar I
Pedigree Series D11S5025 χ2
4 (p-
value)
V289I χ2
1 (p-value) D11S5026 χ2
4 (p-
value)
D11S5027 χ2
3 (p-
value)
D11S5028 χ2
2 (p-
value)
PITT 0.707 (0.93) 0.299 (0.58) 2.061 (0.57) 0.142 (0.98) 1.541 (0.46)
NIMH 0.385 (0.98) 0.012 (0.91) 2.17 (0.47) 0.349 (0.95) 0.396 (0.76)Behavioral and Brain Functions 2006, 2:25 http://www.behavioralandbrainfunctions.com/content/2/1/25
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HMA1a, HMA2/HMA2a and HMB1 define three common
and distinct haplotype groups with frequencies of 45%,
28% and 23%, respectively. These three haplotype groups
differ from each other in at least 7 SNP positions.
The ALG9 haplotype structure in the HapMap database is
similar to the structure defined by D11S5028-V289I
(rs10502151) or D11S5028-V289I (rs10502151)-
D11S5027 in our dataset in that both approaches define
three distinct and common haplotype groups (Table 3
and Additional File 1). Whereas the non-ancestral allele
encoding Ile289 is associated with the common haplo-
types 2.2.2 and 2.2, the ancestral allele encoding Val289 is
associated with two common distinct haplotype groups
1.1.1 and 3.1.1 (three-marker haplotype) or 1.1 and 3.1
(two-marker haplotype) in our dataset (Table 3). The two
common ancestral haplotype groups are tagged by the
106 bp and 114 bp-alleles of D11S5028, whereas the non-
ancestral haplotypes are tagged by the 110 bp-allele
(Table 3), indicating that the repeat alleles of the three
haplotypes differ by at least 4 bp (2 units). Because (CA)n
repeat mutations cause an increase or decrease in repeat
number by one unit [16], we predict that the two ancestral
and one non-ancestral haplotype groups are phylogeneti-
cally distant and correspond to the same three haplotype
groups defined in the HapMap database.
Whereas the two ancestral haplotypes in the HapMap
database, HMA1/HMA1a and HMA2/HMA2a, have fre-
quencies of 45% and 28% respectively (Additional File 1),
those in our study have frequencies of 27% and 23%
(three-marker haplotypes) or 29% and 28% (two-marker
haplotypes) (Table 3). The non-ancestral haplotypes in
the HapMap database (HMB1) and in our study (2.2.2 or
2.2) have comparable frequencies of 23% and 22 or 30%,
respectively. Thus, the frequencies of the common haplo-
types defined by D11S5028-V289I (rs10502151)-
D11S5027 or D11S5028-V289I (rs10502151) and Hap-
Map are comparable. Nevertheless, it is conceivable that if
there is a susceptibility-variant in the most common
ancestral haplotype in HapMap database (HMA1/
HMA1a), our method would have reduced power to
detect it because the frequency of the most common
ancestral haplotypes (1.1.1 or 1.1) in our dataset is lower
than that in the HapMap database (27% or 29% vs. 45%),
thus reducing the number of informative chromosomes
tested for association with bipolar I disorder. If, however,
there is a rare susceptibility variant on haplotype 1.1.1 or
1.1, our approach would have more power to detect it
because of the stronger allelic association of the suscepti-
bility variant with haplotype 1.1.1 or 1.1 than with
HMA1/HMA1a.
If the ALG9 disruption is causally linked to the develop-
ment of BPAD in the translocation family, several other
reasons could be invoked to explain our present failure to
detect an association between ALG9 and BPAD. It is con-
ceivable that rare loss-of-function mutations and gross
gene aberrations of ALG9 that have dramatic functional
consequences, rather than the common allelic and haplo-
typic variations, could increase predisposition to BPAD.
Here, we tested two series of pedigrees. The NIMH pedi-
grees are enriched for families with multiple affected indi-
viduals, whereas 129 of 135 (95.6%) of the PITT pedigrees
contain a single affected individual. If rare susceptibility
variants in ALG9 contribute to the familial enrichment of
BPAD in the NIMH pedigrees, association testing by com-
mon alleles and haplotypes would have low power to
detect it. Although the PITT series is primarily consisted of
small nuclear families with a single affected individual,
Table 3: Allelic association of D11S5028-V289I-D11S5027 and haplotype transmission test
Pedigree series Haplotype D11S5028 
Allele (bp)
V289I Allele 
GTA>ATA
D11S5027 
Allele (bp)
Expected haplotype 
frequency (no allelic 
association)
Observed 
haplotype 
frequency*
Haplotype 
transmission 
disequlibrium p-value
PITT 1.1.1 106 G 366 0.13 0.27 0.78
3.1.1 114 G 366 0.12 0.23 0.90
4.1.1 116 G 366 0.03 0.07 0.70
5.1.1 others G 366 0.02 0.02 0.13
2.1.4 114 G Others 0.01 0.02 0.81
2.2.2 110 A 372 0.02 0.22 0.82
2.2.3 110 A 375 0.05 0.05 0.55
NIMH 1.1 106 G - 0.19 0.29 0.67
3.1 114 G - 0.17 0.28 0.98
4.1 116 G - 0.04 0.05 0.62
5.1 others G - 0.04 0.02 0.67
2.2 110 A - 0.11 0.30 0.78
5.2 others A - 0.02 0.02 0.87
*Only observed-haplotypes that have frequencies more than 2% are shown because the uncommon haplotypes, that have frequencies less than 2%, 
are not analyzed by TRANSMIT.Behavioral and Brain Functions 2006, 2:25 http://www.behavioralandbrainfunctions.com/content/2/1/25
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and therefore might be more suited to detect common,
low-penetrance susceptibility variants, its sample size may
not be large enough if the relative risk of susceptibility
conferred by the common variant is low. It is also conceiv-
able that certain environmental factors or sex-specific
influences may modify the risk conferred by an ALG9 var-
iant. Similar mechanisms may have played a role in fail-
ure to support an association between DISC1 variations
and schizophrenia in some studies [17-20], although an
increasing amount of evidence supports a role for DISC1,
a gene disrupted by a translocation breakpoint in an
extended family, in the etiology of schizophrenia.
Conclusion
In conclusion, our further analysis of ALG9 gene varia-
tions failed to support a major role in predisposition to
BPAD. Nevertheless, we cannot rule out a role for ALG9 in
BPAD susceptibility because of the limitations of the
markers and the pedigrees analyzed here. Interestingly,
another protein N-glycosylation pathway gene, MGAT5
(Mannoside acetylglucosaminyltransferase 5) at chromo-
some band 22q21, was also found to be disrupted by an
unbalanced translocation breakpoint in a schizophrenia
case [2]. Thus, the structural aberrations of sugar trans-
ferase genes in BPAD and schizophrenia and the recent
findings that the germ line homozygous mutations of
ALG9 leads to progressive microcephaly, cerebral and cer-
ebellar atrophy underscores the significance of N-glyco-
sylation pathway in central nervous system homeostasis
and may warrant further analyses of ALG9 and other man-
nosyltransferase genes in the etiopathogenesis of psycho-
sis.
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